Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
BioLineRx Announces USPTO Allowance of New Composition of Matter Patent on Motixafortide
-
CoinDesk bolsters information services offering with strategic acquisition of CCData and CryptoCompare
-
2024 ASDSA Top Advocates Chosen
-
B. Riley Financial Declares Preferred Stock Dividends
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
The Consolidated Mining Standard Initiative launches first public consultation
-
The Devon Group Launches the Clear Communicator Awards to Celebrate Excellence in HR Tech Marketing
-
Square Celebrates Nine Canadian Businesses Ranked Among Top 50 in the World
-
Main Street Announces New Portfolio Investment
-
Aeva Announces Date for Third Quarter 2024 Results and Conference Call
-
Ardagh Metal Packaging-Europe enters Portuguese renewable energy market, securing deal with BNZ
-
Opthea Files Notice of Annual General Meeting
-
Pivotree Announces Letter to Shareholders
-
ASDSA Recognizes 2024 Patient Safety Hero Award Honorees
-
Freightos Reports Record Transactions and Gross Booking Value for Third Quarter of 2024
-
Adicet Bio Announces FDA Clearance of IND Amendment to Evaluate ADI-001 in Idiopathic Inflammatory Myopathy and Stiff Person Syndrome
-
Apogee Therapeutics Announces Poster Presentation at the ACAAI 2024 Annual Scientific Meeting
-
1-In-3 Canadian Grandparents Support Their Children or Grandchildren Financially, Impacting Retirement Plans
-
Hamilton Lane Incorporated to Announce Second Quarter Fiscal 2025 Results on November 6, 2024
-
EPIC Crude Completes Issuance of New $1,200 Million Senior Secured Term Loan B
-
CI Global Asset Management Announces October 2024 Distributions for the CI ETFs
-
Myrobalan Therapeutics Strengthens Board of Directors with Appointment of Emma Reeve
-
Volastra Therapeutics Announces the Appointment of Co-Founder Samuel Bakhoum, M.D., Ph.D., as Chief Scientific Officer
-
Entegris Declares Quarterly Cash Dividend
-
Exscientia Achieves Milestones for Two Programmes in Sanofi Collaboration
-
Old Dominion Freight Line Named #1 National LTL Carrier for Quality by Mastio & Company for 15th Consecutive Year
-
Kyndryl Readiness Report: 90% Confident in IT, but 39% Say It's Future-Ready
-
CRITEO TO ANNOUNCE THIRD QUARTER 2024 FINANCIAL RESULTS ON OCTOBER 30, 2024
-
F&G's Fifth Annual Risk Tolerance Tracker Finds Inflation, U.S. Presidential Election and Cyberfraud Top of Mind for American Investors
-
Bridging the Data Gap: Commercial Freight Insights from Five Key U.S. Bridges
-
Nodenza Venture Partners launched - focus on international early-stage and pre-commercial biotech & medtech opportunities
-
Bicycle Therapeutics to Present Radiopharmaceuticals Data at European Association of Nuclear Medicine 2024 Congress
-
Mohari Hospitality, Omnam Investment Group and Pharrell Williams Partner to Acquire Historic Parisian 5-star Hotel in 1st Arrondissement
-
Recent Publications Affirm the Value of Gene Expression Profile Testing in Guiding a Definitive Diagnosis and Clinical Decision-Making in Melanocytic Lesions of Uncertain Malignant Potential
-
Easily recyclable large-capacity transparent containers are coming: SK chemicals launches 'ECOTRIA CLARO 300' with improved recyclability
-
Pinnacle Global Network Launches 2024 SCALEit® Accelerator Series, Empowering CEOs and Business Owners to Achieve Unprecedented Growth
-
CaryHealth to Sponsor NCQA, Unveiling AI-Driven Solutions to Transform Health Plan Efficiency
-
STP Investment Services Unveils New Compliance Services Practice, STP ComplianceAdvisor, to Meet Growing Demand
-
Iron Mountain Schedules Third Quarter 2024 Earnings Release and Conference Call
-
OKYO Pharma Announces Start of Phase 2 Clinical Trial to Treat Patients with Neuropathic Corneal Pain
-
Revolutionizing Lighting: Superior LED Technologies Unveils Industry's Most Efficient Lights, Setting a New Standard
-
Mesa Air Group Reports Third Quarter Fiscal 2024 Results
-
ACELYRIN, INC. Forms Scientific and Patient Advisory Board Featuring Leading Voices in Thyroid Eye Disease
-
Sagimet Biosciences Announces Upcoming Presentations at AASLD - The Liver Meeting® 2024
-
Hydreight Provides Corporate Update Reflecting Significant Growth
-
Perspective Therapeutics Begins Shipping Investigational Products from State-of-the-Art Radiopharmaceutical Manufacturing Facility in Somerset, New Jersey
-
Barrick Reports Q3 Preliminary Production Results With Continued Improvement at Pueblo Viejo
-
Apellis Announces Oral Presentation at American Society of Nephrology (ASN) Kidney Week on Phase 3 VALIANT Study of Pegcetacoplan in C3G and Primary IC-MPGN
-
Smurfit Westrock to Announce Third Quarter 2024 Financial Results on October 30, 2024
-
Tilray Announces Fall Craft Beer Lineup
